1.Drossman, DA, Camilleri, M, Mayer, EA, Whitehead, WE. AGA technical review on irritable bowel syndrome. Gastroenterology. 2002;123:2108–2131.
2.Levy, RL, Drossman, DA, Francisconi, C, et al. Psychosocial aspects of the functional gastrointestinal diorders. Gastroenterology. In press.
3.Toner, BB, Segal, ZV, Emmott, S, et al. Cognitive-behavioral group therapy for patients with irritable bowel syndrome. Int J Group Psychother. 1998;48:215–243.
4.Toner, B, Segal, Z, Emmott, S, Myran, D. Cognitive-Behavioral Treatment of Irritable Bowel Syndrome: The Brain-Gut Connection. New York, NY: Guilford Press; 2000.
5.Bennett, P, Wilkinson, S. A comparison of psychological and medical treatment of the irritable bowel syndrome.Br J Clin Psychol. 1985;24(pt 3):215–216.
6.Lynch, PM, Zamble, E. A controlled behavioral treatment study of irritable bowel syndrome. Behav Ther. 1989;20:509–523.
7.Shaw, G, Srivastava, ED, Sadlier, M, Swann, P, James, JY, Rhodes, J. Stress management for irritable bowel syndrome: a controlled trial. Digestion. 1991;50:36–42.
8.Rumsey, N. Group stress management programmes vs. pharmacological treatment in the treatment of the irritable bowel syndrome. In: Regis, Lyme, ed. Current Approaches Towards Confident Management of Irritable Bowel Syndrome. London, England: Lyme Regis; 1991:33–39.
9.Corney, RH, Stanton, R, Newell, R, Clare, A, Fairclough, P. Behavioural psychotherapy in the treatment of irritable bowel syndrome. J Psychosom Res. 1991;35:461–469.
10.van Dulmen, AM, Fennis, JF, Bleijenberg, G. Cognitive-behavioral group therapy for irritable bowel syndrome: effects and long-term follow-up. Psychosom Med. 1996;58:508–514.
11.Boyce, PM, Talley, NJ, Balaam, B, Koloski, NA, Truman, G. A randomized controlled trial of cognitive behavior therapy, relaxation training, and routine clinical care for the irritable bowel syndrome. Am J Gastroenterol. 2003;98:2209–2218.
12.Neff, DF, Blanchard, EB. A multi-component treatment for irritable bowel syndrome. Behav Ther. 1987;18:70–83.
13.Blanchard, EB, Schwarz, SP. Adaptation of a multicomponent treatment for irritable bowel syndrome to a small-group format. Biofeedback Self Regul. 1987;12:63–69.
14.Blanchard, EB, Schwarz, SP, Suls, JM, et al. Two controlled evaluations of multi-component psychological treatment of irritable bowel syndrome. Behav Res Ther. 1992;30:175–189.
15.Greene, B, Blanchard, EB. Cognitive therapy for irritable bowel syndrome. J Consult Clin Psychol. 1994;62:576–582.
16.Payne, A, Blanchard, EB. A controlled comparison of cognitive therapy and self-help support groups in the treatment of irritable bowel syndrome. J Consult Clin Psychol. 1995;63:779–786.
17.Vollmer, A, Blanchard, EB. Controlled comparison of individual versus group cognitive therapy for irritable bowel syndrome. Behav Ther. 1998;29:19–33.
18.Drossman, DA, Toner, BB, Whitehead, WE, et al. Cognitive-behavioral therapy versus education and desipramine versus placebo for moderate to severe functional bowel disorders. Gastroenterology. 2003;125:19–31.
19.Creed, F, Bradley, L, Francisconi, C, Drossman, DA, Naliboff, B, Olden, K. Psychosocial aspects of functional gastrointestinal disorders. In: Drossman, DA, Corazziari, E, Talley, NJ, Thompson, WG, Whitehead, WE, eds. Encyclopedia of Gastroenterology. McLean, VA: Degnon Associates; In press.
20.Lydiard, RB, Falsetti, SA. Experience with anxiety and depression treatment studies: Implications for designing irritable bowel syndrome clinical trials. Am J Med. 1999;107:65S–73S.
21.Toner, BB, Stuckless, N, Ali, A, Downie, F, Emmott, S, Akman, D. The development of a cognitive scale for functional bowel disorders. Psychosom Med. 1998;60:492–497.
22.Veldhuyzen van Zanten, SJ, Talley, NJ, Bytzer, P, Klein, K, Whorwell, PJ, Zinsmeister, AR. Design of treatment trials for the functional gastrointestinal disorders. In: Drossman, DA, Corazziari, E, Talley, NJ, Thompson, WG, Whitehead, WE, eds. Rome II: Functional Gastrointestinal Disorders: Diagnosis, Pathophysiology, and Treatment. McLean, VA: Degnon Associates; 2000:577–622.
23.Whitehead, WE, Corazziari, E, Prizont, R, et al. Definition of a responder in clincial trials for functional gastrointestinal disorders. In: Drossman, DA, Corazziari, E, Talley, NJ, et al. eds. Rome II: Functional Gastrointestinal Disorders: Diagnosis, Pathophysiology, and Treatment. McLean, VA: Degnon Associates; 2000:623–627.
24.Thase, ME, Greenhouse, JB, Frank, E, et al. Treatment of major depression with psychotherapy or psychotherapy-pharmacotherapy combinations. Arch Gen Psychiatry. 1997;54:1009–1015.
25.Holroyd, KA, O'Donnell, FJ, Stensland, M, Lipchik, GL, Cordingley, GE, Carlson, BWManagement of chronic tension-type headache with tricyclic antidepressant medication, stress management therapy, and their combination: a randomized controlled trial. JAMA. 2001;285:2208–2215.
26.Keller, MB, McCullough, JP, Klein, DN, et al. A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression. N Engl J Med. 2000;342:1462–1470.
27.Whitehead, WE, Palsson, O, Jones, KR. Systematic review of the comorbidity of irritable bowel syndrome with other disorders: what are the causes and implications? Gastroenterology. 2002;122:1140–1156.
28.Lydiard, RB, Fossey, MD, Marsh, W, Ballenger, JC. Prevalence of psychiatric disorders in patients with irritable bowel syndrome. Psychosomatics. 1993;34:229–234.
29.Barlow, DH, Gorman, JM, Shear, MK, Woods, SW. Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: A randomized controlled trial. JAMA. 2000;283:2529–2536.
30.Creed, FH, Ratcliffe, J, Fernandes, L, et al. Depressive, panic and neurasthenic disorders predict poor outcome in severe irritable bowel syndrome unless suitably treated. Br J Psychiatry. In press.
31.Sperber, AD, Carmel, S, Atzmon, Y, et al. Use of the Functional Bowel Disorder Severity Index (FBDSI) in a study of patients with the irritable bowel syndrome and fibromyalgia. Am J Gastroenterol. 2000;95:995–998.
32.Davis, D, Padesky, C. Ehancing Cognitive Therapy with Women. Comprehensive Handbook of Cognitive Therapy. New York, NY: Plenum Press; 1989:535–557.
33.Toner, BB, Chang, L, Fukudo, S, et al. Gender, age, society, culture and the patient's perspective in the disorders of gastrointestinal function. Gastroenterology. In press.
34.Goodrich, T, Rampage, C, Ellman, B, Halstead, K. Feminist Family Therapy. New York, NY: W.W. Norton & Company; 1988.
35.Ali, A, Oatley, K, Toner, BB. Emotional abuse as a precipitating factor for depression in women. J Emotion Abuse. 1999;1:1–13.
36.Ali, A, Toner, BB. Gender differences in depressive response: the role of social support. Sex Roles. 1996;35:281–293.
37.Williams, DR. Race/ethnicity and socioeconomic status: measurement and methodological issues. Int J Health Serv. 1996;26:483–505.
38.Pinhas, L, Toner, BB, Ali, A, Garfinkel, PE, Stuckless, N. The effects of the ideal of female beauty on mood and body satisfaction. Int J Eat Disord. 1999;25:223–226.
39.Striegel-Moore, R. Psychological factors in the etiology of binge eating. Addict Behav. 1995;20:713–723.
40.Surrey, J. Eating patterns as a reflection women's development. In: Jordan, J, Kaplan, A, Miller, JB, Stiver, I, Surrey, J, eds. Women's Growth in Connection: Writings from the Stone Center. New York, NY: Guildord Press; 1991:237–249.
41.Fodor, IE. Sex role conflict and symptom formation in women. Psychotherapy. 1974;11:22–29.
42.Franks, V, Rothblum, ED. The Stereotyping of Women: In Effects on Mental Health. New York, NY: Brunner-Mazel; 1983.
43.McHugh, MC. A feminist approach to agoraphobia: challenging traditional views of women at home. In: Chrisler, JC, Golden, C, Rozee, PD, eds. Lectures on the Psychology of Women. New York, NY: McGraw-Hill; 1996:339–357.
44.Craig, TK, Brown, GW. Goal frustration and life events in the aetiology of painful gastrointestinal disorder. J Psychosom Res. 1984;28:411–421.
45.DeMarco, C. For Women Only: Take Charge of Your Body. Winlaw, Canada: Well Women Press; 1992.
46.Ali, A, Richardson, DC, Toner, BB. Feminine gender role and illness behavior in irritable bowel syndrome. J Gender Cult Health. 1998;3:59–65.
47.Ali, A, Toner, BB, Stuckless, N, et al. Emotional abuse, self-blame, and self-silencing in women with irritable bowel syndrome. Psychosom Med. 2000;62:76–82.
48.Toner, B. Cognitive-behavioural treatment of functional somatic syndromes: Integrating gender issues. Cogn Behav Pract. 1994;1:157–178.
49.Toner, BB, Akman, D. Gender role and irritable bowel syndrome: literature review and hypothesis. Am J Gastroenterol. 2000;95:11–16.
50.Kennedy, A, Robinson, A, Rogers, A. Incorporating patients' views and experiences of life with IBS in the development of an evidence based self-help guidebook. Patient Educ Couns. 2003;50:303–310.
51.International Foundation for Functional Gastrointestinal Disorders. IBS in the real world survey [pamphlet]. Milwaukee, Wise: International Foundation for Functional Gastrointestinal Disorders; 2002.
52.Bertram, S, Kurland, M, Lydick, E, Locke, GR III, Yawn, BP. The patient's perspective of irritable bowel syndrome. J Fam Pract. 2001;50:521–525.
53.Worell, J, Remer, P. Feminist Perspectives in Therapy: An Empowerment Model for Women. Toronto, Canada: Wiley & Sons; 1992.
54.Toner, B, Chang, L, Fukudo, S, et al. Gender, age, society, culture and the patient's perspective in functional gastrointestinal disorders. In: Drossman, DA, Corazziari, E, Talley, NJ, Thompson, WG, Whitehead, WE, eds. Encyclopedia of Gastroenterology. McLean, VA: Degnon Associates. In press.
55.Fabrege, H Jr. Somatization in cultural-historical perspective. In: Kirmayer, , Robbins, JM, eds. Current Concepts of Somatization: Researach and Clinical Perspectives. Washington, DC: American Psychiatric Press; 1991:181–199.
56.Kirmayer, LJ, Robbins, JM. Functional somatic syndromes. In: Kirmayber, LJ, Robbins, JM, eds. Current Concepts of Somatization. Washington, DC: American Psychiatric Association; 1991:79–105.
57.Lips, H. Sex and Gender. Mountainview, Calif: Mayfield Publishing; 1997.
58.Toner, B, Casati, J. Diseases of the digestive system. In: Perry, N, Johnson, SB, Rozensky, R, eds. Medical Disorders and Behavioral Applications. Washington, DC: American Psychological Association; 2002:283–305.